Tag: Corporate Practices
-
Big Pharma, Big Loopholes: The Unseen Impact of Tax Strategies on Global Healthcare
The recent revelations about pharmaceutical firms stashing profits in Europe’s tax havens have once again kindled a heated debate about corporate ethics, tax policies, and their real-world impacts on drug prices and patient care. With 15 of the largest pharmaceutical companies amassing profits of €580 billion over five years, while deploying intricate tax avoidance structures,…